MEMANTINE Side Effects

7024427-7 | Breast Cancer Metastatic, Metastases To Bone
on Sep 18, 2010 Female patient from GERMANY , 86 years of age, was treated with Memantine (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer metastatic, metastases to bone. Memantine dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with RIVASTIGMINE (RIVASTIGMINE) (RIVASTIGMINE) (View Rivastigmine (rivastigmine) (rivastigmine) Review and Rivastigmine (rivastigmine) (rivastigmine) Label ).

7021599-5 | Faecal Incontinence, Urinary Incontinence
Patient was taking Memantine (View Usage). Patient had the following side effects: faecal incontinence, urinary incontinence (What is urinary incontinence?) on Sep 20, 2010 from GERMANY Additional patient health information: Male patient , 68 years of age, weighting 149.9 lb, . Memantine dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with GINKGO BILOBA LEAVE (GINKGO BILOBA LEAVE) (View Ginkgo Biloba Leave (ginkgo Biloba Leave) Review and Ginkgo Biloba Leave (ginkgo Biloba Leave) Label ), YINDENGNAOTONG (View Yindengnaotong Review and Yindengnaotong Label ), SHUXUETONG (SHUXUETONG) (SHUXUETONG) (View Shuxuetong (shuxuetong) (shuxuetong) Review and Shuxuetong (shuxuetong) (shuxuetong) Label ), GANGLIOSIDES (CEREBRAL CORTEX) (CEREBRAL CORTEX) (View Gangliosides (cerebral Cortex) (cerebral Cortex) Review and Gangliosides (cerebral Cortex) (cerebral Cortex) Label ), DANHONG (DANHONG (DANHONG) (View Danhong (danhong (danhong) Review and Danhong (danhong (danhong) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7020526-4 | Accidental Overdose, Confusional State, Somnolence, Speech Disorder
Adverse event was reported on Sep 15, 2010 by a Female patient taking Memantine (View Usage) (Dosage: 20 Mg (10 Mg, 2 In 1 D), Oral; 200 Mg (100 Mg, 2 In 1 D)) was diagnosed with dementia alzheimer's type and. Location: GERMANY , 73 years of age, weighting 114.6 lb, After Memantine was administered, patient had the following side effects: accidental overdose, confusional state, somnolence, speech disorder. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), THYROXINE (LEVOTHYROXINE) (LEVOTHYROXINE) (View Thyroxine (levothyroxine) (levothyroxine) Review and Thyroxine (levothyroxine) (levothyroxine) Label ), SIMVASTATIN (SIMVASTATIN) (SUSPENSION) (SIMVASTATIN) (View Simvastatin (simvastatin) (suspension) (simvastatin) Review and Simvastatin (simvastatin) (suspension) (simvastatin) Label ), PROMAZINE (PROMAZINE) (SOLUTION) (PROMAZINE) (View Promazine (promazine) (solution) (promazine) Review and Promazine (promazine) (solution) (promazine) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

7012899-3 |
on Sep 09, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). . Memantine dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with INSULIN (INSULIN) (INSULIN) (View Insulin (insulin) (insulin) Review and Insulin (insulin) (insulin) Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), NICERGOLINE (NICERGOLINE) (NICERGOLINE) (View Nicergoline (nicergoline) (nicergoline) Review and Nicergoline (nicergoline) (nicergoline) Label ), LOVASTATIN (LOVASTATIN) (LOVASTATIN) (View Lovastatin (lovastatin) (lovastatin) Review and Lovastatin (lovastatin) (lovastatin) Label ).


7012897-X |
on Sep 09, 2010 Female patient from GERMANY , 78 years of age, was diagnosed with dementia alzheimer's type, major depression and was treated with Memantine (View Usage). . Memantine dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ESCITALOPRAM (10 Mg (10 Mg, 1 In 1 D)) (View Escitalopram Review and Escitalopram Label ), AMISULPRIDE (AMISULPRIDE) (View Amisulpride (amisulpride) Review and Amisulpride (amisulpride) Label ), TRAVOPROST (TRAVOPROST) (TRAVOPROST) (View Travoprost (travoprost) (travoprost) Review and Travoprost (travoprost) (travoprost) Label ), DORZOLAMIDE/TIMOLOL (DORZOLAMIDE, TIMOLOL) (DORZOLAMIDE, TIMOLOL) (View Dorzolamide/timolol (dorzolamide, Timolol) (dorzolamide, Timolol) Review and Dorzolamide/timolol (dorzolamide, Timolol) (dorzolamide, Timolol) Label ), BRINZOLAMIDE (BRINZOLAMIDE) (BRINZOLAMIDE) (View Brinzolamide (brinzolamide) (brinzolamide) Review and Brinzolamide (brinzolamide) (brinzolamide) Label ).

6973102-3 | Fatigue, Heat Stroke, Nausea, Retching
Patient was taking Memantine (View Usage). After Memantine was administered, patient had the following side effects: fatigue, heat stroke, nausea (What is nausea?), retching on Aug 23, 2010 from GERMANY Additional patient health information: Female patient , 75 years of age, weighting 158.7 lb, was diagnosed with dementia alzheimer's type and. Memantine dosage: 20 Mg (20 Mg, 1 In 1 D). During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ). Patient was hospitalized.

6942718-2 | Accidental Overdose, Somnolence
Adverse event was reported on Aug 09, 2010 by a Male patient taking Memantine (View Usage) (Dosage: 40 Pumps 10 Mg/g (once), Oral, 20 Mg (10 Mg, 2 In 1 D), Oral) was diagnosed with dementia alzheimer's type and. Location: GERMANY , 80 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, somnolence.

6939572-1 | Apathy, Communication Disorder, Personality Disorder, Social Avoidant Behaviour, Speech Disorder, Tongue Spasm
on Aug 05, 2010 Female patient from GERMANY , 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). Patient had the following side effects: apathy, communication disorder, personality disorder (What is personality disorder?), social avoidant behaviour, speech disorder, tongue spasm. Memantine dosage: 10 Mg, Oral. During the same period patient was treated with MEMANTINE HCL (Oral) (View Memantine Hcl Review and Memantine Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GALANTAMINE (View Galantamine Review and Galantamine Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6936747-2 | Condition Aggravated, Convulsion, Convulsive Threshold Lowered
on Aug 02, 2010 Male patient from GERMANY , 59 years of age, weighting 165.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). After Memantine was administered, patient had the following side effects: condition aggravated, convulsion, convulsive threshold lowered. Memantine dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with DELEPSINE (VALPROATE SODIUM) (TABLETS) (VALPROATE SODIUM) (View Delepsine (valproate Sodium) (tablets) (valproate Sodium) Review and Delepsine (valproate Sodium) (tablets) (valproate Sodium) Label ), ZOLOFT (SERTRALINE HYDROCHLORIDE) (TABLETS) (SERTRALINE HYDROCHLORIDE) (View Zoloft (sertraline Hydrochloride) (tablets) (sertraline Hydrochloride) Review and Zoloft (sertraline Hydrochloride) (tablets) (sertraline Hydrochloride) Label ), OXAZEPAM (OXAZEPAM) (TABLETS) (OXAZEPAM) (View Oxazepam (oxazepam) (tablets) (oxazepam) Review and Oxazepam (oxazepam) (tablets) (oxazepam) Label ), VIOXX (ROFECOXIB) (ROFECOXIB) (View Vioxx (rofecoxib) (rofecoxib) Review and Vioxx (rofecoxib) (rofecoxib) Label ).

6924207-4 | Altered State Of Consciousness, Cerebral Ischaemia, Convulsion, Gait Disturbance, Pyrexia, Respiratory Distress
Patient was taking Memantine (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, cerebral ischaemia, convulsion, gait disturbance, pyrexia, respiratory distress on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 192.9 lb, . Memantine dosage: . During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PEPCID (View Pepcid Review and Pepcid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6913700-6 | Rash Pruritic, Urticaria
Adverse event was reported on Jul 21, 2010 by a Male patient taking Memantine (View Usage) (Dosage: 10 Mg (10 Mg, In 1 D), Oral) was diagnosed with dementia (What is dementia?) and. Location: GERMANY , 76 years of age, Patient had the following side effects: rash pruritic, urticaria. During the same period patient was treated with CIPRAMIL (CITALOPRAM HYDROBROMIDE) (TABLETS) (CITALOPRAM HYDROBROMIDE) (View Cipramil (citalopram Hydrobromide) (tablets) (citalopram Hydrobromide) Review and Cipramil (citalopram Hydrobromide) (tablets) (citalopram Hydrobromide) Label ), MIXTARD INSULIN (SUSPENSION) (View Mixtard Insulin (suspension) Review and Mixtard Insulin (suspension) Label ), ARICEPT (DONEPEZIL HYDROCHLORIDE) (TABLETS) (DONEPEZIL HYDROCHLORIDE) (View Aricept (donepezil Hydrochloride) (tablets) (donepezil Hydrochloride) Review and Aricept (donepezil Hydrochloride) (tablets) (donepezil Hydrochloride) Label ). Patient was hospitalized.

6913692-X | Granulocytopenia, Leukopenia, Thrombocytopenia
on Jul 19, 2010 Female patient from GERMANY , 90 years of age, weighting 103.6 lb, was diagnosed with dementia alzheimer's type, psoriasis and was treated with Memantine (View Usage). After Memantine was administered, patient had the following side effects: granulocytopenia, leukopenia, thrombocytopenia. Memantine dosage: 20 Mg (10 Mg, 2 In 1 D),oral. During the same period patient was treated with METHOTREXATE (2.5 Mg, Oral) (View Methotrexate Review and Methotrexate Label ), PERSANTIN RETARD (200, TABLETS) (View Persantin Retard (200, Tablets) Review and Persantin Retard (200, Tablets) Label ). Patient was hospitalized.

6840906-7 | Ascites, Back Pain, Bile Duct Obstruction, Blood Calcium Decreased, Candida Test Positive, Cholelithiasis, Colonic Obstruction, Enterococcal Bacteraemia, Enterococcus Test Positive
on Jul 01, 2010 Female patient from UNITED STATES , 91 years of age, weighting 124.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, back pain (What is back pain?), bile duct obstruction, blood calcium decreased, candida test positive, cholelithiasis, colonic obstruction, enterococcal bacteraemia, enterococcus test positive. Memantine dosage: 20 Mg 910 Mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT ((10 Mg), Oral) (View Aricept Review and Aricept Label ), ACTONEL (View Actonel Review and Actonel Label ), CELEBREX (View Celebrex Review and Celebrex Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MVI WITH FOLIC ACID (View Mvi With Folic Acid Review and Mvi With Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.

6822055-7 | Agitation, Fall, Musculoskeletal Stiffness, Sneezing
Patient was taking Memantine (View Usage). Patient had the following side effects: agitation, fall (What is fall?), musculoskeletal stiffness, sneezing on Jun 22, 2010 from GERMANY Additional patient health information: Female patient , 99 years of age, was diagnosed with dementia alzheimer's type, sneezing and. Memantine dosage: 20 Mg, Oral. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), SINEMET (View Sinemet Review and Sinemet Label ), ADIRO (View Adiro Review and Adiro Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ATARAX (View Atarax Review and Atarax Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6785100-3 | Fall, Musculoskeletal Stiffness
Adverse event was reported on Jun 07, 2010 by a Female patient taking Memantine (View Usage) (Dosage: 40 Gtt (10 Gtt, 4 In 1 D), Oral) was diagnosed with dementia alzheimer's type, sneezing and. Location: GERMANY , 99 years of age, After Memantine was administered, patient had the following side effects: fall (What is fall?), musculoskeletal stiffness. During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), SINEMET (View Sinemet Review and Sinemet Label ), ADIRO (View Adiro Review and Adiro Label ), ACETYLSYSTEINE (View Acetylsysteine Review and Acetylsysteine Label ). Patient was hospitalized.

6785099-X | Accidental Overdose, Somnolence
on Jun 07, 2010 Male patient from GERMANY , 80 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, somnolence. Memantine dosage: 40 Pumps 10 Mg/g (once), Oral; 20 Mg (10 Mg, 2 In 1 D), Oral.

6713469-4 | Abnormal Behaviour, Apathy, Bradycardia, Confusional State, Dehydration, Faecaloma, Haematocrit Increased, Hyperglycaemia, Hypernatraemia
on Apr 21, 2010 Female patient from GERMANY , 85 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). Patient had the following side effects: abnormal behaviour, apathy, bradycardia, confusional state, dehydration, faecaloma, haematocrit increased, hyperglycaemia, hypernatraemia. Memantine dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), SPIRONOLACTONE/ALTIZIDE (View Spironolactone/altizide Review and Spironolactone/altizide Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6711391-0 | Chest Pain, Dyspnoea, Leukocytosis, Pneumonia Aspiration, Productive Cough
Patient was taking Memantine (View Usage). After Memantine was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, leukocytosis, pneumonia aspiration, productive cough on May 04, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 135.3 lb, . Memantine dosage: 85 Mg. During the same period patient was treated with CLOTRIMAZOLE TROCHE (View Clotrimazole Troche Review and Clotrimazole Troche Label ), DUONEB MININEB (View Duoneb Minineb Review and Duoneb Minineb Label ), HYDROMORPHONE INJ IVP (View Hydromorphone Inj Ivp Review and Hydromorphone Inj Ivp Label ), ZOLPIDEM TAB (View Zolpidem Tab Review and Zolpidem Tab Label ), ALBUTEROL SULFATE MININEB (View Albuterol Sulfate Minineb Review and Albuterol Sulfate Minineb Label ), ASPIRIN BUFFERED TAB (View Aspirin Buffered Tab Review and Aspirin Buffered Tab Label ), AUGMENTIN TAB (View Augmentin Tab Review and Augmentin Tab Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ). Patient was hospitalized.

6581927-1 | Confusional State
Adverse event was reported on Feb 12, 2010 by a Male patient taking Memantine (View Usage) (Dosage: 5 Mg Every Day Po) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 76 years of age, weighting 194.9 lb, Patient experienced the following unwanted or unexpected effects: confusional state.

4781019-8 | Bronchitis, Circulatory Collapse, Cyanosis, Dyspnoea, Fatigue, Heart Rate Increased, Livedo Reticularis, Oedema Peripheral, Pulmonary Oedema
on Sep 21, 2005 Female patient from SWEDEN , 70 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), circulatory collapse, cyanosis, dyspnoea, fatigue, heart rate increased, livedo reticularis, oedema peripheral, pulmonary oedema. Memantine dosage: 10 Mg Qd Po. During the same period patient was treated with CITALOPRAM (20 Mg Qd Po) (View Citalopram Review and Citalopram Label ), MOVICOL (View Movicol Review and Movicol Label ), TOPIMAX (TOPIRAMATE) (View Topimax (topiramate) Review and Topimax (topiramate) Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), STESOLID (DIAZEPAM) (View Stesolid (diazepam) Review and Stesolid (diazepam) Label ), PROGYNON (ESTRADIOL VALERATE) (View Progynon (estradiol Valerate) Review and Progynon (estradiol Valerate) Label ), LAXOBERAL (View Laxoberal Review and Laxoberal Label ).

4776324-5 | Bronchitis, Circulatory Collapse, Cyanosis, Dyspnoea, Fatigue, Heart Rate Increased, Oedema Peripheral, Pulmonary Oedema, Pupil Fixed
on Sep 07, 2005 Female patient from SWEDEN , 70 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). After Memantine was administered, patient had the following side effects: bronchitis (What is bronchitis?), circulatory collapse, cyanosis, dyspnoea, fatigue, heart rate increased, oedema peripheral, pulmonary oedema, pupil fixed. Memantine dosage: 10 Mg Qd Po. During the same period patient was treated with CITALOPRAM (20 Mg Qd Po) (View Citalopram Review and Citalopram Label ), MOVICOL (View Movicol Review and Movicol Label ), TOPIMAX (TOPIRAMATE) (View Topimax (topiramate) Review and Topimax (topiramate) Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), STESOLID (DIAZEPAM) (View Stesolid (diazepam) Review and Stesolid (diazepam) Label ), PROGUNON (ESTRADIOL VALERATE) (View Progunon (estradiol Valerate) Review and Progunon (estradiol Valerate) Label ), LAXOBERAL (View Laxoberal Review and Laxoberal Label ).

4745152-9 |
Patient was taking Memantine (View Usage). on Jul 29, 2005 from SPAIN Additional patient health information: Female patient , 83 years of age, was diagnosed with dementia alzheimer's type and. Memantine dosage: .

4745129-3 | Abdominal Pain, Condition Aggravated
Adverse event was reported on Jul 30, 2005 by a Female patient taking Memantine (View Usage) (Dosage: 5 Mg Qd Po) was diagnosed with dementia alzheimer's type and. Location: GERMANY , 84 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), condition aggravated. During the same period patient was treated with GALANTAMINE HYDROBROMIDE (8 Mg Qd) (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), VALERIANA OFFICINALIS ROOT (VALERIANA OFFICINALIS ROOT DRY EXTRACT) (View Valeriana Officinalis Root (valeriana Officinalis Root Dry Extract) Review and Valeriana Officinalis Root (valeriana Officinalis Root Dry Extract) Label ). Patient was hospitalized.

4669224-2 | Acute Myocardial Infarction, Depressed Level Of Consciousness, Hypertension, Urinary Tract Infection
on May 03, 2005 Female patient from , 86 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine (View Usage). After Memantine was administered, patient had the following side effects: acute myocardial infarction, depressed level of consciousness, hypertension, urinary tract infection (What is urinary tract infection?). Memantine dosage: 20 Mg Qd Po. During the same period patient was treated with DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CALCIFEROL (View Calciferol Review and Calciferol Label ). Patient was hospitalized.

4638725-5 | Aggression, Blood Pressure Increased
on Apr 18, 2005 Male patient from , 73 years of age, weighting 160.9 lb, was diagnosed with dementia (What is dementia?) and was treated with Memantine (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, blood pressure increased. Memantine dosage: 5 Mg Po Bid.

4604861-2 | Urinary Tract Infection
Patient was taking Memantine (View Usage). Patient had the following side effects: urinary tract infection (What is urinary tract infection?) on Jan 14, 2005 from Additional patient health information: Female patient , 87 years of age, was diagnosed with dementia alzheimer's type and. Memantine dosage: 10 Mg Bid Po. During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

4553879-7 |
Adverse event was reported on Jan 13, 2005 by a Female patient taking Memantine (View Usage) (Dosage: 10 Mg Po Bid) . Location: , 81 years of age, weighting 169.0 lb, . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), NORVASC (View Norvasc Review and Norvasc Label ), ARICEPT (View Aricept Review and Aricept Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ).

4553878-5 |
on Jan 13, 2005 Male patient from , 64 years of age, weighting 196.0 lb, was treated with Memantine (View Usage). . Memantine dosage: 10 Mg Po Bid. During the same period patient was treated with EXULON (View Exulon Review and Exulon Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), DEPAKOTE (View Depakote Review and Depakote Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), SINEMET (View Sinemet Review and Sinemet Label ).

4553877-3 | Abasia, Lethargy
on Jan 13, 2005 Female patient from , 79 years of age, weighting 126.0 lb, was treated with Memantine (View Usage). Patient had the following side effects: abasia, lethargy. Memantine dosage: 10 Mg Po Bid. During the same period patient was treated with FELODIPINE (View Felodipine Review and Felodipine Label ), ZANTAC (View Zantac Review and Zantac Label ), DILANTIN (View Dilantin Review and Dilantin Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ARICEPT (View Aricept Review and Aricept Label ).

4525756-9 | Convulsion, Fatigue, Urinary Tract Infection
Patient was taking Memantine (View Usage). After Memantine was administered, patient had the following side effects: convulsion, fatigue, urinary tract infection (What is urinary tract infection?) on Jul 23, 2004 from Additional patient health information: Female patient , 83 years of age, was diagnosed with dementia alzheimer's type and. Memantine dosage: 5 Mg Qd Po. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.